News News September, 2019 IGM Biosciences Announces Pricing of Initial Public Offering Read More... July, 2019 IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline Read More... January, 2019 IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors Read More... January, 2019 IGM Biosciences Appoints Misbah Tahir as Chief Financial Officer Read More... November, 2018 IGM Biosciences Appoints Wayne Godfrey, M.D., as Vice President, Clinical Development Read More... August, 2018 IGM Biosciences Appoints Julie Hambleton, M.D., to Board of Directors Read More... August, 2018 IGM Biosciences Appoints Daniel S. Chen, M.D., Ph.D., as Chief Medical Officer; Names William Strohl, Ph.D., to Board of Directors Read More... « Previous 1 2 3 4
